comparemela.com

Latest Breaking News On - Stéphane bancel - Page 2 : comparemela.com

Moderna CEO: 2024 is year of growth, with 2023 transition in rearview

Moderna posted strong results despite investors assuming a loss for the year.

Stéphane bancelFlu vaccinesCovid vaccineRsv vaccine

Moderna Stock Soars After Cancer Vaccine s Strong Test Results

he drug company’s latest vaccine, built from the same mRNA technology that created the Covid-19 vaccine, was found to significantly reduce risk of relapse or death from melanoma.

Arpa garayStephen hogePresident stephen hogeChief commercial officer arpaModerna stockStéphane bancel

Moderna announces global regulatory submissions for respiratory syncytial virus vaccine

mRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.

Drug administrationTherapeutic goods administrationEuropean unionEuropean medicines agencyBiologics license applicationChief executive officerTherapy designationFast trackPriority pathwayPriority determinationModerna newsMrna 1345Respiratory syncytial virus vaccineStéphane bancelRespiratory syncytial virus

Moderna CEO Draws Criticism for Earning $400M in Stock, Getting Raise

The exec donated $176 million after-tax to charity last year and pledged to continue, but analysts still aren't sure he should be making so much.

Weekend bi usStéphane bancelOrdan hart

Bernie Sanders Holds a Moderna Show Trial

The Vermont socialist is upset the company may make a profit on its Covid vaccine.

United statesBernie sandersVermont senatorBiotechnology servicesHealthcare life sciencesSpecialized drugs medicationsRegulation government policyFinancial performanceNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingPolitical general newsRespiratory tract diseasesMedical conditions

vimarsana © 2020. All Rights Reserved.